Postoperative Antimicrobial Prophylaxis Versus Placebo for Infection Prevention in HCC After Liver Resection
Status:
Suspended
Trial end date:
2021-07-01
Target enrollment:
Participant gender:
Summary
This trial is a multi-center, double-blinded, randomized (1:1) clinical trial. The aim is to
compare the postoperative infection rate between the 3 days postoperative AMP group and the
placebo group in HCC patients undergoing hepatectomy.